Three years after litigation started over technology used in Comirnaty, the mRNA vaccine for COVID-19, Biontech SE is acquiring its adversary, Curevac NV, through an all-stock transaction valued at ...

South Korea’s LigaChem Biosciences has signed two antibody licensing agreements with US biotech NovaRock Biotherapeutics, reports Korea Biomedical Review.

USA-based biotech Vaxart has reported positive top-line results from a Phase I trial comparing its second-generation oral ...

A California-based biotech company stole the show on Wednesday after the company reported positive clinical data ...

Vaxart (NASDAQ:VXRT) stock jumped 37.9% premarket after the company reported positive early-stage data for its ...

Vaxart's (VXRT) shares soar 37% after positive early trial results for its oral norovirus vaccine. Read more here.

Pending the outcome of this process, LeddarTech does not expect to resume active operations and cautions investors that there is significant risk that holders of our securities will receive little to ...

Globally, norovirus is associated with approximately one-fifth of all diarrhea cases (Lopman BA et al 2016, with a similar ...

Stitch Fix reported quarterly losses of six cents per share, which beat the analyst consensus estimate of losses of 11 cents per share. Quarterly revenue came in at $325.02 million, beating the ...

Customers can try the Chocolate-on-the-Inside upgrade for free with the purchase of a waffle cone or waffle bowl of Kilwins ...

Meeting adjourned to June 13, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 12, 2025 ...

Neutralizing antibodies tested 90 days after infection were greater in participants who had been vaccinated before their ...